Cargando…

Current therapeutic approaches to diffuse grade II and III gliomas

The 2016 WHO classification of Tumors of the Central Nervous System brought major conceptual and practical changes in the classification of diffuse gliomas, by combining molecular features and histology into ‘integrated’ diagnoses. In diffuse gliomas, molecular profiling has thus become essential fo...

Descripción completa

Detalles Bibliográficos
Autores principales:	Picca, Alberto, Berzero, Giulia, Sanson, Marc
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	SAGE Publications 2018
Materias:	Special Collection: Neuro-oncology: Practice-Changing Developments
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5791552/ https://www.ncbi.nlm.nih.gov/pubmed/29403544 http://dx.doi.org/10.1177/1756285617752039

Ejemplares similares

Off-label use of IV t-PA in patients with intracranial neoplasm and cavernoma
por: Schwarzbach, Christopher Jan, et al.
Publicado: (2018)

Apparent diffusion coefficient for molecular subtyping of non-gadolinium-enhancing WHO grade II/III glioma: volumetric segmentation versus two-dimensional region of interest analysis
por: Thust, S. C., et al.
Publicado: (2018)

Comprehensive Genomic Profiling of 282 Pediatric Low‐ and High‐Grade Gliomas Reveals Genomic Drivers, Tumor Mutational Burden, and Hypermutation Signatures
por: Johnson, Adrienne, et al.
Publicado: (2017)

WHO grade has no prognostic value in the pediatric high-grade glioma included in the HERBY trial
por: Varlet, Pascale, et al.
Publicado: (2020)

Dynamic CT perfusion imaging of intra-axial brain tumours: differentiation of high-grade gliomas from primary CNS lymphomas
por: Schramm, Peter, et al.
Publicado: (2010)

Impact of the revised WHO classification of diffuse low-grade glioma on clinical decision making: A case report
por: van der Vlis, Tim A. M. Bouwens, et al.
Publicado: (2017)

Defining Treatment‐Related Adverse Effects in Patients with Glioma: Distinctive Features of Pseudoprogression and Treatment‐Induced Necrosis
por: Winter, Sebastian F., et al.
Publicado: (2020)

Bevacizumab in recurrent WHO grades II–III glioma
por: Annakib, Soufyan, et al.
Publicado: (2023)

Targeting reduced mitochondrial DNA quantity as a therapeutic approach in pediatric high-grade gliomas
por: Shen, Han, et al.
Publicado: (2020)

Astrocytic tumour grading: a comparative study of three-dimensional pseudocontinuous arterial spin labelling, dynamic susceptibility contrast-enhanced perfusion-weighted imaging, and diffusion-weighted imaging
por: Xiao, Hua-Feng, et al.
Publicado: (2015)

A nationwide evaluation of bevacizumab-based treatments in pediatric low-grade glioma in the UK: Safety, efficacy, visual morbidity, and outcomes
por: Green, Katherine, et al.
Publicado: (2022)

Association between hippocampal dose and memory in survivors of childhood or adolescent low-grade glioma: a 10-year neurocognitive longitudinal study
por: Acharya, Sahaja, et al.
Publicado: (2019)

Ependymal enhancement on magnetic resonance imaging for the identification of high-grade gliomas
por: Waqas, Muhammad, et al.
Publicado: (2017)

Serum endocan levels before and after surgery on low-grade gliomas
por: Tanriverdi, Taner, et al.
Publicado: (2017)

Lower Grade Gliomas
por: Youssef, Gilbert, et al.
Publicado: (2020)

The future of high-grade glioma: Where we are and where are we going
por: Rhun, Emilie Le, et al.
Publicado: (2015)

Non-invasive assessment of glioma microstructure using VERDICT MRI: correlation with histology
por: Zaccagna, Fulvio, et al.
Publicado: (2019)

Early postoperative MRI overestimates residual tumour after resection of gliomas with no or minimal enhancement
por: Belhawi, Sinan M. K., et al.
Publicado: (2011)

Glioma imaging in Europe: A survey of 220 centres and recommendations for best clinical practice
por: Thust, S. C., et al.
Publicado: (2018)

New diffusion metrics for spondylotic myelopathy at an early clinical stage
por: Hori, Masaaki, et al.
Publicado: (2012)

Alternative lengthening of telomeres (ALT) in pediatric high-grade gliomas can occur without ATRX mutation and is enriched in patients with pathogenic germline mismatch repair (MMR) variants
por: Stundon, Jennifer L, et al.
Publicado: (2022)

Dual IGF1R/IR inhibitors in combination with GD2-CAR T-cells display a potent anti-tumor activity in diffuse midline glioma H3K27M-mutant
por: de Billy, Emmanuel, et al.
Publicado: (2021)

Grading of carotid artery stenosis with multidetector-row CT angiography: visual estimation or caliper measurements?
por: Waaijer, Annet, et al.
Publicado: (2009)

Intensity standardization of MRI prior to radiomic feature extraction for artificial intelligence research in glioma—a systematic review
por: Fatania, Kavi, et al.
Publicado: (2022)

Inter-observer reproducibility of quantitative dynamic susceptibility contrast and diffusion MRI parameters in histogram analysis of gliomas
por: Dijkstra, Hildebrand, et al.
Publicado: (2019)

Diffusion-tensor-based method for robust and practical estimation of axial and radial diffusional kurtosis
por: Tachibana, Yasuhiko, et al.
Publicado: (2015)

MRI shows thickening and altered diffusion in the median and ulnar nerves in multifocal motor neuropathy
por: Haakma, Wieke, et al.
Publicado: (2016)

Diffusion MRI of the facial-vestibulocochlear nerve complex: a prospective clinical validation study
por: Shapey, Jonathan, et al.
Publicado: (2023)

Brain volume perfusion CT performed with 128-detector row CT system in patients with cerebral gliomas: A feasibility study
por: Xyda, Argyro, et al.
Publicado: (2011)

Serial H3K27M cell-free tumor DNA (cf-tDNA) tracking predicts ONC201 treatment response and progression in diffuse midline glioma
por: Cantor, Evan, et al.
Publicado: (2022)

MRI software for diffusion-perfusion mismatch analysis may impact on patients’ selection and clinical outcome
por: Pistocchi, Silvia, et al.
Publicado: (2021)

Analysis of normal-appearing white matter of multiple sclerosis by tensor-based two-compartment model of water diffusion
por: Tachibana, Yasuhiko, et al.
Publicado: (2015)

Impact of intravenous alteplase on sub-angiographic emboli in high-resolution diffusion-weighted imaging following successful thrombectomy
por: Broocks, Gabriel, et al.
Publicado: (2021)

Fluorescein for resection of high-grade gliomas: A safety study control in a single center and review of the literature
por: Francaviglia, Natale, et al.
Publicado: (2017)

Automated MRI perfusion-diffusion mismatch estimation may be significantly different in individual patients when using different software packages
por: Deutschmann, Hannes, et al.
Publicado: (2020)

COVD-18. POTENTIAL TO HARNESS SARS-COV-2 NEUROTROPISM IN THE DELIVERY OF ONCOLYTIC VIROTHERAPY FOR THE TREATMENT OF HIGH-GRADE GLIOMA
por: Immidisetti, Amanda, et al.
Publicado: (2020)

Facing Contrast-Enhancing Gliomas: Perfusion MRI in Grade III and Grade IV Gliomas according to Tumor Area
por: Di Stefano, Anna Luisa, et al.
Publicado: (2014)

Atypical primary central nervous system lymphoma and glioblastoma: multiparametric differentiation based on non-enhancing volume, apparent diffusion coefficient, and arterial spin labeling
por: Yu, Xiaojun, et al.
Publicado: (2023)

Glioblastoma post-operative imaging in neuro-oncology: current UK practice (GIN CUP study)
por: Booth, Thomas C., et al.
Publicado: (2020)

Challenges for the functional diffusion map in pediatric brain tumors
por: Grech-Sollars, Matthew, et al.
Publicado: (2014)

Cannot write session to /tmp/vufind_sessions/sess_8ppf5vd8savsoifsrslssnamc6